MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 263 filers reported holding MIRATI THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.48 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,170,152 | +78.5% | 26,863 | +48.1% | 0.00% | 0.0% |
| Q2 2023 | $655,398 | +7.4% | 18,140 | +10.6% | 0.00% | 0.0% |
| Q1 2023 | $609,976 | -11.6% | 16,406 | +7.7% | 0.00% | 0.0% |
| Q4 2022 | $689,891 | -46.2% | 15,226 | -17.0% | 0.00% | 0.0% |
| Q3 2022 | $1,282,000 | +0.5% | 18,354 | -3.4% | 0.00% | 0.0% |
| Q2 2022 | $1,276,000 | -10.1% | 19,008 | +10.1% | 0.00% | 0.0% |
| Q1 2022 | $1,419,000 | -88.5% | 17,262 | -80.2% | 0.00% | -90.0% |
| Q4 2021 | $12,340,000 | +277.6% | 87,165 | +330.3% | 0.01% | +233.3% |
| Q2 2021 | $3,268,000 | +8.0% | 20,257 | +14.6% | 0.00% | 0.0% |
| Q1 2021 | $3,027,000 | -20.0% | 17,673 | +2.5% | 0.00% | -25.0% |
| Q4 2020 | $3,786,000 | +760.5% | 17,239 | +187.3% | 0.00% | +300.0% |
| Q1 2019 | $440,000 | – | 6,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avoro Capital Advisors LLC | 1,000,000 | $31,470,000 | 8.67% |
| Baker Brothers Advisors | 2,805,074 | $88,276,000 | 0.77% |
| Broadfin Capital, LLC | 359,661 | $11,319,000 | 0.61% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 397,660 | $12,514,000 | 0.42% |
| Boulegeris Investments, Inc. | 17,415 | $548,000 | 0.39% |
| SPHERA FUNDS MANAGEMENT LTD. | 95,000 | $2,990,000 | 0.29% |
| Rhenman & Partners Asset Management AB | 50,000 | $1,574,000 | 0.19% |
| Integre Asset Management, LLC | 23,996 | $755,000 | 0.16% |
| Orbimed Advisors | 680,500 | $21,415,000 | 0.16% |
| EAM Investors, LLC | 38,754 | $1,220,000 | 0.14% |